Cancer-Related Fatigue: State of the Science

PM and R

Volumn 2, Issue 5, 2010, Pages 364-383

  Mitchell, Sandra A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMFEBUTAMONE; ANTIANEMIC AGENT; ASCORBIC ACID; CARNITINE; CELECOXIB; DEXMETHYLPHENIDATE; DOCOSAHEXAENOIC ACID; DONEPEZIL; HERBACEOUS AGENT; ICOSAPENTAENOIC ACID; MEDROXYPROGESTERONE; METHYLPHENIDATE; MODAFINIL; OMEGA 3 FATTY ACID; PAROXETINE; POLYPHENOL; PROTIRELIN; VENLAFAXINE; VISCUM ALBUM LECTIN;

ACUPUNCTURE; AGITATION; ANEMIA; ANOREXIA; AROMATHERAPY; ARTICLE; CAUSAL ATTRIBUTION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COGNITIVE THERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG USE; ENERGY BALANCE; EXERCISE; FATIGUE; GINSENG; HUMAN; INCIDENCE; INSOMNIA; MASSAGE; NAUSEA; NEOPLASM; PREDICTION; PRIORITY JOURNAL; PSYCHOEDUCATION; QUALITY OF LIFE; REHABILITATION CARE; RISK FACTOR; SCREENING TEST; SIDE EFFECT; TREATMENT INDICATION; TREATMENT RESPONSE; VOMITING; XEROSTOMIA; YOGA;

ANEMIA; COMORBIDITY; COMPLEMENTARY THERAPIES; FATIGUE; HEMATINICS; HUMANS; NEOPLASMS;

EID: 77952858956     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2010.03.024     Document Type: Article

References (328)

1. Cella D., Peterman A., Passik S., Jacobsen P., and Breitbart W. Progress toward guidelines for the management of fatigue. Oncology 12 (1998) 369-377
2. Curt G. Impact of fatigue on quality of life in oncology patients. Semin Hematol 37 4 Suppl 6 (2000) 14-17
3. Mallinson T., Cella D., Cashy J., and Holzner B. Giving meaning to measure: Linking self-reported fatigue and function to performance of everyday activities. J Pain Symptom Manage 31 (2006) 229-241
4. Curt G., and Johnston P.G. Cancer fatigue: The way forward. Oncologist 8 Suppl 1 (2003) 27-30
5. de Jong N., Candel M.J., Schouten H.C., Abu-Saad H.H., and Courtens A.M. Course of the fatigue dimension "activity level" and the interference of fatigue with daily living activities for patients with breast cancer receiving adjuvant chemotherapy. Cancer Nurs 29 (2006) E1-E13
6. Dimeo F., Schmittel A., Fietz T., et al. Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Ann Oncol 15 (2004) 1237-1242
7. Andrykowski M.A., Curran S.L., and Lightner R. Off-treatment fatigue in breast cancer survivors: A controlled comparison. J Behav Med 21 (1998) 1-18
8. Lindqvist O., Widmark A., and Rasmussen B.H. Meanings of the phenomenon of fatigue as narrated by 4 patients with cancer in palliative care. Cancer Nurs 27 (2004) 237-243
9. Magnusson K., Moller A., Ekman T., and Wallgren A. A qualitative study to explore the experience of fatigue in cancer patients. Eur J Cancer Care (Engl) 8 (1999) 224-232
10. Rao A.V., and Cohen H.J. Fatigue in older cancer patients: Etiology, assessment, and treatment. Semin Oncol 35 (2008) 633-642
11. Servaes P., Verhagen S., and Bleijenberg G. Determinants of chronic fatigue in disease-free breast cancer patients: A cross-sectional study. Ann Oncol 13 (2002) 589-598
12. Wang X.S., Giralt S.A., Mendoza T.R., et al. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol 20 (2002) 1319-1328
13. Mystakidou K., Parpa E., Katsouda E., Galanos A., and Vlahos L. The role of physical and psychological symptoms in desire for death: A study of terminally ill cancer patients. Psychooncology 15 (2006) 355-360
14. Hockenberry-Eaton M., and Hinds P.S. Fatigue in children and adolescents with cancer: Evolution of a program of study. Semin Oncol Nurs 16 (2000) 261-272 discussion 272-278
15. Vogelzang N.J., Breitbart W., Cella D., et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34 3 Suppl 2 (1997) 4-12
16. Knowles G., Borthwick D., McNamara S., Miller M., and Leggot L. Survey of nurses' assessment of cancer-related fatigue. Eur J Cancer Care (Engl) 9 (2000) 105-113
17. Shun S.C., Lai Y.H., and Hsiao F.H. Patient-related barriers to fatigue communication in cancer patients receiving active treatment. Oncologist 14 (2009) 936-943
18. Collins S., de Vogel-Voogt E., Visser A., and van der Heide A. Presence, communication and treatment of fatigue and pain complaints in incurable cancer patients. Patient Educ Couns 72 (2008) 102-108
19. Passik S.D., Kirsh K.L., Donaghy K., et al. Patient-related barriers to fatigue communication: Initial validation of the fatigue management barriers questionnaire. J Pain Symptom Manage 24 (2002) 481-493
20. Cancer-related fatigue (version 1.2010). National Comprehensive Cancer Network (2010). http://www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf Accessed January 2, 2010
21. Cella D., Lai J.S., Chang C.H., Peterman A., and Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94 (2002) 528-538
22. Glaus A., Crow R., and Hammond S. A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Eur J Cancer Care 5 2 Suppl (1996) 8-23
23. Wu H.S., and McSweeney M. Cancer-related fatigue: "It's so much more than just being tired.". Eur J Oncol Nurs 11 (2007) 117-125
24. Andrykowski M.A., Schmidt J.E., Salsman J.M., Beacham A.O., and Jacobsen P.B. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol 23 (2005) 6613-6622
25. Yavuzsen T., Davis M.P., Ranganathan V.K., et al. Cancer-related fatigue: Central or peripheral?. J Pain Symptom Manage 38 (2009) 587-596
26. Sadler I.J., Jacobsen P.B., Booth-Jones M., Belanger H., Weitzner M.A., and Fields K.K. Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. J Pain Symptom Manage 23 (2002) 406-416
27. Tchekmedyian N.S., Kallich J., McDermott A., Fayers P., and Erder M.H. The relationship between psychologic distress and cancer-related fatigue. Cancer 98 (2003) 198-203
28. Jacobsen P.B., Donovan K.A., and Weitzner M.A. Distinguishing fatigue and depression in patients with cancer. Semin Clin Neuropsychiatry 8 (2003) 229-240
29. Capuron L., Gumnick J.F., Musselman D.L., et al. Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26 (2002) 643-652
30. Reuter K., and Harter M. The concepts of fatigue and depression in cancer. Eur J Cancer Care (Engl) 13 (2004) 127-134
31. Van Belle S., Paridaens R., Evers G., et al. Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: Proposal for use as a screening tool. Support Care Cancer 13 (2005) 246-254
32. Hinshaw D.B., Carnahan J.M., and Johnson D.L. Depression, anxiety, and asthenia in advanced illness. J Am Coll Surg 195 2 (2002) 271-277
33. Valentine A.D., and Meyers C.A. Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer 92 6 Suppl (2001) 1694-1698
34. Lai J.-S., Cella D., Dineen K., et al. An item bank was created to improve the measurement of cancer-related fatigue. J Clin Epidemiol 58 2 (2005) 190-197
35. Lee B.N., Dantzer R., Langley K.E., et al. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11 5 (2004) 279-292
36. Bower J.E., Ganz P.A., and Aziz N. Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosom Med 67 (2005) 277-280
37. Ahlberg K., Ekman T., Gaston-Johansson F., and Mock V. Assessment and management of cancer-related fatigue in adults. Lancet 362 (2003) 640-650
38. Prue G., Rankin J., Allen J., Gracey J., and Cramp F. Cancer-related fatigue: A critical appraisal. Eur J Cancer 42 (2006) 846-863
39. Kuhnt S., Ernst J., Singer S., et al. Fatigue in cancer survivors-prevalence and correlates. Onkologie 32 (2009) 312-317
40. Servaes P., Verhagen C., and Bleijenberg G. Fatigue in cancer patients during and after treatment: Prevalence, correlates and interventions. Eur J Cancer 38 (2002) 27-43
41. Butt Z., Rosenbloom S.K., Abernethy A.P., et al. Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. J Natl Compr Canc Netw 6 (2008) 448-455
42. Bower J.E., Ganz P.A., Desmond K.A., et al. Fatigue in long-term breast carcinoma survivors: A longitudinal investigation. Cancer 106 4 (2006) 751-758
43. Andrykowski M.A., Carpenter J.S., Greiner C.B., et al. Energy level and sleep quality following bone marrow transplantation. Bone Marrow Transplant 20 (1997) 669-679
44. Young K.E., and White C.A. The prevalence and moderators of fatigue in people who have been successfully treated for cancer. J Psychosom Res 60 (2006) 29-38
45. Hjermstad M.J., Oldervoll L., Fossa S.D., Holte H., Jacobsen A.B., and Loge J.H. Quality of life in long-term Hodgkin's disease survivors with chronic fatigue. Eur J Cancer 42 (2006) 327-333
46. Johnsen A., Petersen M., Pedersen L., and Groenvold M. Symptoms and problems in a nationally representative sample of advanced cancer patients. Palliat Med 23 (2009) 491-501
47. Glaus A., Boehme C., Thurlimann B., et al. Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Ann Oncol 17 (2006) 801-806
48. Beck S.L., Dudley W.N., and Barsevick A. Pain, sleep disturbance, and fatigue in patients with cancer: Using a mediation model to test a symptom cluster. Oncol Nurs Forum 32 (2005) 542
49. Bender C.M., Ergyn F.S., Rosenzweig M.Q., Cohen S.M., and Sereika S.M. Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nurs 28 (2005) 219-225
50. Chow E., Fan G., Hadi S., and Filipczak L. Symptom clusters in cancer patients with bone metastases. Support Care Cancer 30 15 (2007) 1035-1043
51. Francoeur R.B. The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation. J Pain Symptom Manage 29 (2005) 130-155
52. Walsh D., and Rybicki L. Symptom clustering in advanced cancer. Support Care Cancer 14 (2006) 831-836
53. al-Majid S., and McCarthy D.O. Cancer-induced fatigue and skeletal muscle wasting: The role of exercise. Biol Res Nurs 2 (2001) 186-197
54. Wagner L.I., and Cella D. Fatigue and cancer: Causes, prevalence and treatment approaches. Br J Cancer 91 (2004) 822-828
55. Stasi R., Abriani L., Beccaglia P., Terzoli E., and Amadori S. Cancer-related fatigue: Evolving concepts in evaluation and treatment. Cancer 98 (2003) 1786-1801
56. Iop A., Manfredi A.M., and Bonura S. Fatigue in cancer patients receiving chemotherapy: An analysis of published studies. Ann Oncol 15 (2004) 712-720
57. Morrow G.R., Shelke A.R., Roscoe J.A., Hickok J.T., and Mustian K. Management of cancer-related fatigue. Cancer Invest 23 (2005) 229-239
58. Tavio M., Milan I., and Tirelli U. Cancer-related fatigue. (review). Int J Oncol 21 (2002) 1093-1099
59. Nail L.M. Fatigue in patients with cancer. Oncol Nurs Forum 29 (2002) 537
60. Nail L.M. My get up and go got up and went: Fatigue in people with cancer. J Natl Cancer Inst Monogr (2004) 72-75
61. Strasser F., Palmer J.L., Schover L.R., et al. The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: A pilot study. Cancer 107 (2006) 2949-2957
62. Paddison J.S., Temel J.S., Fricchione G.L., and Pirl W.F. Using the differential from complete blood counts as a biomarker of fatigue in advanced non-small-cell lung cancer: An exploratory analysis. Palliat Support Care 7 (2009) 213-217
63. Sateia M.J., and Lang B.J. Sleep and cancer: Recent developments. Curr Oncol Rep 10 (2008) 309-318
64. Ray M., Rogers L.Q., Trammell R.A., and Toth L.A. Fatigue and sleep during cancer and chemotherapy: Translational rodent models. Comp Med 58 (2008) 234-245
65. Jones L.W., Eves N.D., Haykowsky M., Freedland S.J., and Mackey J.R. Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol 10 (2009) 598-605
66. Capuano G., Gentile P.C., Bianciardi F., Tosti M., Palladino A., and Di Palma M. Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 18 (2009) 433-437
67. Bower J.E. Cancer-related fatigue: Links with inflammation in cancer patients and survivors. Brain Behav Immun 21 (2007) 863-871
68. Collado-Hidalgo A., Bower J.E., Ganz P.A., Cole S.W., and Irwin M.R. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 12 (2006) 2759-2766
69. Schubert C., Hong S., Natarajan L., Mills P.J., and Dimsdale J.E. The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review. Brain Behav Immun 21 (2007) 413-427
70. Wood L.J., Nail L.M., Gilster A., Winters K.A., and Elsea C.R. Cancer chemotherapy-related symptoms: Evidence to suggest a role for proinflammatory cytokines. Oncol Nurs Forum 33 (2006) 535-542
71. Ancoli-Israel S., Liu L., Marler M.R., et al. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 14 (2006) 201-209
72. Bower J.E., Ganz P.A., Dickerson S.S., Petersen L., Aziz N., and Fahey J.L. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 30 (2005) 92-100
73. Massacesi C., Terrazzino S., Marcucci F., et al. Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan-based chemotherapy. Cancer 106 (2006) 1007-1016
74. Miller A.H., Ancoli-Israel S., Bower J.E., Capuron L., and Irwin M.R. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26 (2008) 971-982
75. Ryan J.L., Carroll J.K., Ryan E.P., Mustian K.M., Fiscella K., and Morrow G.R. Mechanisms of cancer-related fatigue. Oncologist 12 Suppl 1 (2007) 22-34
76. Kumari M., Badrick E., Chandola T., et al. Cortisol secretion and fatigue: Associations in a community based cohort. Psychoneuroendocrinology 34 (2009) 1476-1485
77. Hrushesky W.J., Grutsch J.F., Wood P., et al. Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr Cancer Ther 8 (2009) 387-397
78. Bower J.E., Ganz P.A., Tao M.L., et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res 15 (2009) 5534-5540
79. Basen-Engquist K., Scruggs S., Jhingran A., et al. Physical activity and obesity in endometrial cancer survivors: Associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol 200 (2009) 288 e281-288
80. Cerchietti L.C., Navigante A.H., and Castro M.A. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer. Nutr Cancer 59 (2007) 14-20
81. Berger A.M., Farr L.A., Kuhn B.R., Fischer P., and Agrawal S. Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J Pain Symptom Manage 33 (2007) 398-409
82. Fernandes R., Stone P., Andrews P., Morgan R., and Sharma S. Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: Evaluation of diagnostic criteria for cancer-related fatigue. J Pain Symptom Manage 32 (2006) 245-254
83. Collado-Hidalgo A., Bower J.E., Ganz P.A., Irwin M.R., and Cole S.W. Cytokine gene polymorphisms and fatigue in breast cancer survivors: Early findings. Brain Behav Immun 22 (2008) 1197-1200
84. Jager A., Sleijfer S., and van der Rijt C.C. The pathogenesis of cancer related fatigue: Could increased activity of pro-inflammatory cytokines be the common denominator?. Eur J Cancer 44 (2008) 175-181
85. Piper B., Lindsey A., and Dodd M. Fatigue mechanisms in cancer patients: Developing nursing theory. Oncology Nursing Forum 14 (1987) 17-23
86. Irvine D., Vincent L., Graydon J.E., Bubela N., and Thompson L. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs 17 (1994) 367-378
87. Winningham M.L. Strategies for managing cancer-related fatigue syndrome: A rehabilitation approach. Cancer 15 92 4 Suppl (2001) 988-997
88. Andrews P., Morrow G.R., Hickok J., Roscoe J., and Stone P. Mechanisms and models of fatigue associated with cancer and its treatment: Evidence from preclinical and clinical studies. In: Armes J., Krishnasamy M., and Higginson I. (Eds). Fatigue in Cancer (2004), Oxford University Press, Oxford 51-87
89. Aistars J. Fatigue in the cancer patient: A conceptual approach to a clinical problem. Oncol Nurs Forum 14 (1987) 25-30
90. Rhoten D. Fatigue and the postsurgical patient. In: Norris C. (Ed). Conceptual Clarification in Nursing (1982), Aspen, Rockville, MD 277-300
91. Glaus A. Fatigue in patients with cancer. Analysis and assessment. Recent Results Cancer Res 145 (1998) I-XI, 1-172
92. Olson K. A new way of thinking about fatigue: A reconceptualization. Oncology Nursing Forum 34 (2007) 93-99
93. Olson K., Turner A.R., Courneya K.S., et al. Possible links between behavioral and physiological indices of tiredness, fatigue, and exhaustion in advanced cancer. Support Care Cancer 16 (2008) 241-249
94. Payne J.K. A neuroendocrine-based regulatory fatigue model. Biol Res Nurs 6 (2004) 141-150
95. Al-Majid S., and Gray D.P. A biobehavioral model for the study of exercise interventions in cancer-related fatigue. Biol Res Nurs 10 (2009) 381-391
96. Khoshknabi D.S., Davis M.P., Ranganathan V.K., et al. Combining objective and subjective outcomes in cancer-related fatigue: Illustrations from a single case report. J Palliat Med 11 (2008) 829-833
97. Monga U., Jaweed M., Kerrigan A.J., et al. Neuromuscular fatigue in prostate cancer patients undergoing radiation therapy. Arch Phys Med Rehabil 78 (1997) 961-966
98. Grossman P., Deuring G., Garland S.N., Campbell T.S., and Carlson L.E. Patterns of objective physical functioning and perception of mood and fatigue in posttreatment breast cancer patients and healthy controls: An ambulatory psychophysiological investigation. Psychosom Med 70 (2008) 819-828
99. Servaes P., Verhagen C., and Bleijenberg G. Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: Daily self-report and objective behavior. Cancer 95 (2002) 2017-2026
100. Davis K.M., Lai J.S., Hahn E.A., and Cella D. Conducting routine fatigue assessments for use in clinical oncology practice: Patient and provider perspectives. Support Care Cancer 16 (2008) 379-386
101. Hwang S.S., Chang V.T., and Kasimis B.S. A comparison of three fatigue measures in veterans with cancer. Cancer Invest 21 (2003) 363-373
102. Kirsh K.L., Passik S., Holtsclaw E., Donaghy K., and Theobald D. I get tired for no reason: A single item screening for cancer-related fatigue. J Pain Symptom Manage 22 (2001) 931-937
103. Temel J.S., Pirl W.F., Recklitis C.J., Cashavelly B., and Lynch T.J. Feasibility and validity of a one-item fatigue screen in a thoracic oncology clinic. J Thorac Oncol 1 (2006) 454-459
104. Danjoux C., Gardner S., and Fitch M. Prospective evaluation of fatigue during a course of curative radiotherapy for localised prostate cancer. Support Care Cancer 15 (2007) 1169-1176
105. Butt Z., Wagner L.I., Beaumont J.L., et al. Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage 35 (2008) 20-30
106. Butt Z., Wagner L.I., Beaumont J.L., et al. Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapy. Support Care Cancer 16 (2008) 151-159
107. Strasser F., Muller-Kaser I., and Dietrich D. Evaluating cognitive, emotional, and physical fatigue domains in daily practice by single-item questions in patients with advanced cancer: A cross-sectional pragmatic study. J Pain Symptom Manage 38 (2009) 505-514
108. Mark T.L., Fortner B., and Johnson G. Evaluation of a tablet PC technology to screen and educate oncology patients. Support Care Cancer 16 (2008) 371-378
109. Banthia R., Malcarne V.L., Roesch S.C., et al. Correspondence between daily and weekly fatigue reports in breast cancer survivors. J Behav Med 29 (2006) 269-279
110. Mota D.D., and Pimenta C.A. Self-report instruments for fatigue assessment: A systematic review. Res Theory Nurs Pract 20 (2006) 49-78
111. Wagner L., and Cella D. Cancer related fatigue: Clinical screening, assessment and management. In: Marty M., and Pecorelli S. (Eds). ESO Scientific Updates: Fatigue, Asthenia, Exhaustion and Cancer. 5th ed. (2001), Elsevier Science, Oxford, England 201-214
112. Minton O., and Stone P. A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol 20 (2009) 17-25
113. Whitehead L. The measurement of fatigue in chronic illness: A systematic review of unidimensional and multidimensional fatigue measures. J Pain Symptom Manage 37 (2009) 107-128
114. Mendoza T.R., Wang X.S., Cleeland C.S., et al. The rapid assessment of fatigue severity in cancer patients: Use of the Brief Fatigue Inventory. Cancer 85 (1999) 1186-1196
115. Hwang S.S., Chang V.T., Cogswell J., and Kasimis B.S. Clinical relevance of fatigue levels in cancer patients at a Veterans Administration Medical Center. Cancer 94 (2002) 2481-2489
116. Chang Y.J., Lee J.S., Lee C.G., et al. Assessment of clinical relevant fatigue level in cancer. Support Care Cancer 15 (2007) 891-896
117. Okuyama T., Tanaka K., Akechi T., et al. Fatigue in ambulatory patients with advanced lung cancer: Prevalence, correlated factors, and screening. J Pain Symptom Manage 22 (2001) 554-564
118. Holley S.K. Evaluating patient distress from cancer-related fatigue: An instrument development study. Oncol Nurs Forum 27 (2000) 1425-1431
119. Armes J., Chalder T., Addington-Hall J., Richardson A., and Hotopf M. A randomized controlled trial to evaluate the effectiveness of a brief, behaviorally oriented intervention for cancer-related fatigue. Cancer 110 (2007) 1385-1395
120. Alexander S., Minton O., and Stone P.C. Evaluation of screening instruments for cancer-related fatigue syndrome in breast cancer survivors. J Clin Oncol 27 (2009) 1197-1201
121. Goligher E.C., Pouchot J., Brant R., et al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol 35 (2008) 635-642
122. Pouchot J., Kherani R.B., Brant R., et al. Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis. J Clin Epidemiol 61 7 (2008) 705-713
123. Yellen S.B., Cella D.F., Webster K., Blendowski C., and Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13 2 (1997) 63-74
124. Cella D., Eton D.T., Lai J.S., Peterman A.H., and Merkel D.E. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 24 (2002) 547-561
125. Dittner A.J., Wessely S.C., and Brown R.G. The assessment of fatigue: A practical guide for clinicians and researchers. J Psychosom Res 56 (2004) 157-170
126. Hann D.M., Jacobsen P.B., Azzarello L.M., et al. Measurement of fatigue in cancer patients: Development and validation of the Fatigue Symptom Inventory. Qual Life Res 7 (1998) 301-310
127. Hann D.M., Denniston M.M., and Baker F. Measurement of fatigue in cancer patients: Further validation of the Fatigue Symptom Inventory. Qual Life Res 9 (2000) 847-854
128. Donovan K.A., Jacobsen P.B., Small B.J., Munster P.N., and Andrykowski M.A. Identifying clinically meaningful fatigue with the Fatigue Symptom Inventory. J Pain Symptom Manage 36 (2008) 480-487
129. Krupp L.B., LaRocca N.G., Muir-Nash J., and Steinberg A.D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46 (1989) 1121-1123
130. Hinds P.S., Hockenberry M., Tong X., et al. Validity and reliability of a new instrument to measure cancer-related fatigue in adolescents. J Pain Symptom Manage 34 (2007) 607-618
131. Stein K.D., Martin S.C., Hann D.M., and Jacobsen P.B. A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 6 (1998) 143-152
132. Stein K.D., Jacobsen P.B., Blanchard C.M., and Thors C. Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage 27 (2004) 14-23
133. Smets E.M., Garssen B., Bonke B., and De Haes J.C. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39 (1995) 315-325
134. Fillion L., Gelinas C., Simard S., Savard J., and Gagnon P. Validation evidence for the French Canadian adaptation of the Multidimensional Fatigue Inventory as a measure of cancer-related fatigue. Cancer Nurs 26 (2003) 143-154
135. Purcell A., Fleming J., Bennett S., Burmeister B., and Haines T. Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population. Support Care Cancer 18 (2010) 307-315
136. Belza B.L. Comparison of self-reported fatigue in rheumatoid arthritis and controls. J Rheumatol 22 (1995) 639-643
137. Piper B.F., Dibble S.L., Dodd M.J., Weiss M.C., Slaughter R.E., and Paul S.M. The revised Piper Fatigue Scale: Psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25 (1998) 677-684
138. Mota D.D., Pimenta C.A., and Piper B.F. Fatigue in Brazilian cancer patients, caregivers, and nursing students: A psychometric validation study of the Piper Fatigue Scale-Revised. Support Care Cancer 17 (2009) 645-652
139. Schneider R.A. Reliability and validity of the Multidimensional Fatigue Inventory (MFI-20) and the Rhoten Fatigue Scale among rural cancer outpatients. Cancer Nurs 21 (1998) 370-373
140. Schwartz A.L. The Schwartz Cancer Fatigue Scale: Testing reliability and validity. Oncol Nurs Forum 25 (1998) 711-717
141. Schwartz A.L., Meek P.M., Nail L.M., et al. Measurement of fatigue. determining minimally important clinical differences. J Clin Epidemiol 55 (2002) 239-244
142. Lee K.A., Hicks G., and Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res 36 (1991) 291-298
143. Meek P.M., Nail L.M., Barsevick A., et al. Psychometric testing of fatigue instruments for use with cancer patients. Nurs Res 49 (2000) 181-190
144. Schwartz A.H. Validity of cancer-related fatigue instruments. Pharmacotherapy 22 (2002) 1433-1441
145. Varricchio C.G. Measurement and assessment: What are the issues?. In: Winingham M.L., and Barton-Burke M. (Eds). Fatigue in Cancer: A Multidimensional Approach (2000), Jones and Bartlett, Boston 55-68
146. Wu H.S., and McSweeney M. Measurement of fatigue in people with cancer. Oncol Nurs Forum 28 (2001) 1371-1384 quiz 1385-1376
147. Lind L., and Karlsson D. A system for symptom assessment in advanced palliative home healthcare using digital pens. Med Inform Internet Med 29 (2004) 199-210
148. Cella D., Gershon R., Lai J.S., and Choi S. The future of outcomes measurement: Item banking, tailored short-forms, and computerized adaptive assessment. Qual Life Res 16 Suppl 1 (2007) 133-141
149. Jones J.B., Snyder C.F., and Wu A.W. Issues in the design of Internet-based systems for collecting patient-reported outcomes. Qual Life Res 16 (2007) 1407-1417
150. Carpenter J.S., Rawl S., Porter J., et al. Oncology outpatient and provider responses to a computerized symptom assessment system. Oncol Nurs Forum 35 (2008) 661-669
151. Hacker E.D., and Ferrans C.E. Ecological momentary assessment of fatigue in patients receiving intensive cancer therapy. J Pain Symptom Manage 33 (2007) 267-275
152. Curran S.L., Beacham A.O., and Andrykowski M.A. Ecological momentary assessment of fatigue following breast cancer treatment. J Behav Med 27 (2004) 425-444
153. Radbruch L., Strasser F., Elsner F., et al. Fatigue in palliative care patients-an EAPC approach. Palliat Med 22 (2008) 13-32
154. Cheville A.L. Cancer-related fatigue. Phys Med Rehabil Clin N Am 20 (2009) 405-416
155. Nourissat A., Vasson M.P., Merrouche Y., et al. Relationship between nutritional status and quality of life in patients with cancer. Eur J Cancer 44 (2008) 1238-1242
156. Mitchell S., Beck S., Hood L., Moore K., and Tanner E. Putting evidence into practice (PEP): Evidence-based interventions for fatigue during and following cancer and its treatment. Clin J Oncol Nursing 11 (2007) 99-113
157. Kangas M., Bovbjerg D.H., and Montgomery G.H. Cancer-related fatigue: A systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull 134 (2008) 700-741
158. Minton O., Richardson A., Sharpe M., Hotopf M., and Stone P. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst 100 (2008) 1155-1166
159. Jacobsen P.B., Donovan K.A., Vadaparampil S.T., and Small B.J. Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol 26 (2007) 660-667
160. Cramp F., and Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev (2008) CD006145
161. Goedendorp M.M., Gielissen M.F., Verhagen C.A., and Bleijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev (2009) CD006953
162. Agteresch H.J., Dagnelie P.C., van der Gaast A., Stijnen T., and Wilson J.H. Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 92 (2000) 321-328
163. Cullum J.L., Wojciechowski A.E., Pelletier G., and Simpson J.S. Bupropion sustained release treatment reduces fatigue in cancer patients. Can J Psychiatry 49 (2004) 139-144
164. Moss E.L., Simpson J.S., Pelletier G., and Forsyth P. An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. Psychooncology 15 (2006) 259-267
165. Bruera E., Strasser F., Shen L., et al. The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: A pilot study. J Pain Symptom Manage 26 (2003) 1049-1054
166. Shaw E.G., Rosdhal R., D'Agostino Jr. R.B., et al. Phase II study of donepezil in irradiated brain tumor patients: Effect on cognitive function, mood, and quality of life. J Clin Oncol 24 (2006) 1415-1420
167. Bruera E., El Osta B., Valero V., et al. Donepezil for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 25 (2007) 3475-3481
168. Auret K.A., Schug S.A., Bremner A.P., and Bulsara M. A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. J Pain Symptom Manage 37 (2009) 613-621
169. Lower E.E., Fleishman S., Cooper A., et al. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: A randomized clinical trial. J Pain Symptom Manage 38 (2009) 650-662
170. Butler Jr. J.M., Case L.D., Atkins J., et al. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys 69 (2007) 1496-1501
171. Mar Fan H.G., Clemons M., Xu W., et al. A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer 16 (2008) 577-583
172. Bruera E., Valero V., Driver L., et al. Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 24 (2006) 2073-2078
173. Hanna A., Sledge G., Mayer M.L., et al. A phase II study of methylphenidate for the treatment of fatigue. Support Care Cancer 14 (2006) 210-215
174. Johnson R.L., Block I., Gold M.A., Markwell S., and Zupancic M. Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer. Psychooncology (Nov 16, 2009) Epub
175. Bruera E., Driver L., Barnes E.A., et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: A preliminary report. J Clin Oncol 21 (2003) 4439-4443
176. Sarhill N., Walsh D., Nelson K.A., Homsi J., LeGrand S., and Davis M.P. Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot study. Am J Hosp Palliat Care 18 (2001) 187-192
177. Schwartz A., Thompson J., and Masood N. Interferon-induced fatigue in patients with melanoma: A pilot study of exercise and methylphenidate. Oncol Nurs Forum 29 (2002) E85-E90
178. Sugawara Y., Akechi T., Shima Y., et al. Efficacy of methylphenidate for fatigue in advanced cancer patients: A preliminary study. Palliat Med 16 (2002) 261-263
179. Morrow G.R., Hickok J.T., Roscoe J.A., et al. Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 21 (2003) 4635-4641
180. Roscoe J.A., Morrow G.R., Hickok J.T., et al. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res 89 (2005) 243-249
181. Weitzner M.A., Moncello J., Jacobsen P.B., and Minton S. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage 23 (2002) 337-345
182. Zick S.M., Sen A., Feng Y., Green J., Olatunde S., and Boon H. Trial of essiac to ascertain its effect in women with breast cancer (TEA-BC). J Alternative Complementary Med 12 (2006) 971-980
183. Barton D.L., Soori G.S., Bauer B.A., et al. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: A randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer 18 (2010) 179-187
184. Schumacher K., Schneider B., Reich G., et al. Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study. Anticancer Res 23 (2003) 5081-5087
185. Beuth J., Schneider B., and Schierholz J.M. Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: A controlled multicenter comparative epidemiological cohort study. Anticancer Res 28 (2008) 523-527
186. Cruciani R.A., Dvorkin E., Homel P., et al. L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: A preliminary analysis. Ann N Y Acad Sci 1033 (2004) 168-176
187. Cruciani R.A., Dvorkin E., Homel P., et al. Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: A phase I/II study. J Pain Symptom Manage 32 (2006) 551-559
188. Gramignano G., Lusso M.R., Madeddu C., et al. Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy. Nutrition 22 (2006) 136-145
189. Graziano F., Bisonni R., Catalano V., et al. Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients. Br J Cancer 86 (2002) 1854-1857
190. Cruciani R.A., Dvorkin E., Homel P., et al. L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: A double-blind, placebo-controlled study. J Pain Symptom Manage 37 (2009) 622-631
191. Yeom C.H., Jung G.C., and Song K.J. Changes of terminal cancer patients' health-related quality of life after high dose vitamin C administration. J Korean Med Sci 22 (2007) 7-11
192. Blackhall L., Petroni G., Shu J., Baum L., and Farace E. A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue. J Palliat Med 12 (2009) 433-439
193. Cooper M.R., Bird H.M., and Steinberg M. Efficacy and safety of modafinil in the treatment of cancer-related fatigue. Ann Pharmacother 43 (2009) 721-725
194. Spathis A., Dhillan R., Booden D., Forbes K., Vrotsou K., and Fife K. Modafinil for the treatment of fatigue in lung cancer: A pilot study. Palliat Med 23 (2009) 325-331
195. Read J.A., Beale P.J., Volker D.H., Smith N., Childs A., and Clarke S.J. Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: A phase II trial. Support Care Cancer 15 (2007) 301-307
196. Bruera E., Strasser F., Palmer J.L., et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: A double-blind, placebo-controlled study. J Clin Oncol 21 (2003) 129-134
197. da Costa Miranda V., Trufelli D.C., Santos J., et al. Effectiveness of guarana (Paullinia cupana) for postradiation fatigue and depression: Results of a pilot double-blind randomized study. J Altern Complement Med 15 (2009) 431-433
198. Kamath J., Yarbrough G.G., Prange Jr. A.J., and Winokur A. Thyrotropin-releasing hormone can relieve cancer-related fatigue: Hypothesis and preliminary observations. J Int Med Res 37 (2009) 1152-1157
199. Khan Q.J., Reddy P.S., Kimler B.F., et al. Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 119 (2010) 111-118
200. Mantovani G., Maccio A., Madeddu C., et al. A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress. Cancer Epidemiol Biomarkers Prev 15 (2006) 1030-1034
201. Cerchietti L.C., Navigante A.H., Peluffo G.D., et al. Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: A pilot study. J Pain Symptom Manage 27 (2004) 85-95
202. Jensen M.B., and Hessov I. Randomization to nutritional intervention at home did not improve postoperative function, fatigue or well-being. Br J Surg 84 (1997) 113-118
203. Gadsby J.G., Franks A., Jarvis P., and Dewhurst F. Acupuncture-like transcutaneous electrical nerve stimulation within palliative care: A pilot study. Complementary Ther Med 5 (1997) 13-18
204. Mao J.J., Bruner D.W., Stricker C., et al. Feasibility trial of electroacupuncture for aromatase inhibitor-related arthralgia in breast cancer survivors. Integr Cancer Ther 8 (2009) 123-129
205. Balk J., Day R., Rosenzweig M., and Beriwal S. Pilot, randomized, modified, double-blind, placebo-controlled trial of acupuncture for cancer-related fatigue. J Soc Integr Oncol 7 (2009) 4-11
206. Vickers A.J., Straus D.J., Fearon B., and Cassileth B.R. Acupuncture for postchemotherapy fatigue: A phase II study. J Clin Oncol 22 (2004) 1731-1735
207. Mao J.J., Styles T., Cheville A., Wolf J., Fernandes S., and Farrar J.T. Acupuncture for nonpalliative radiation therapy-related fatigue: Feasibility study. J Soc Integr Oncol 7 (2009) 52-58
208. Davidson J.R., Waisberg J.L., Brundage M.D., and Maclean A.W. Nonpharmacologic group treatment of insomnia: A preliminary study with cancer survivors. Psycho-Oncology 10 (2001) 389-397
209. Espie C.A., Fleming L., Cassidy J., et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol 26 (2008) 4651-4658
210. Savard J., Simard S., Ivers H., and Morin C.M. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncol 23 (2005) 6083-6096
211. Gielissen M.F., Verhagen S., Witjes F., and Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: A randomized controlled trial. J Clin Oncol 24 (2006) 4882-4887
212. Dirksen S.R., and Epstein D.R. Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors. J Adv Nurs 61 (2008) 664-675
213. Quesnel C., Savard J., Simard S., Ivers H., and Morin C.M. Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer. J Consulting Clin Psychol 71 (2003) 189-200
214. Dalton J.A., Keefe F.J., Carlson J., and Youngblood R. Tailoring cognitive-behavioral treatment for cancer pain. Pain Manag Nurs 5 (2004) 3-18
215. Strong V., Waters R., Hibberd C., et al. Management of depression for people with cancer (SMaRT oncology 1): A randomised trial. Lancet 372 (2008) 40-48
216. Berger A.M., VonEssen S., Khun B.R., et al. Feasibility of a sleep intervention during adjuvant breast cancer chemotherapy. Oncology Nursing Forum 29 (2002) 1431-1441
217. Berger A.M., VonEssen S., Kuhn B.R., et al. Adherence, sleep, and fatigue outcomes after adjuvant breast cancer chemotherapy: Results of a feasibility intervention study. Oncology Nursing Forum 30 (2003) 513-522
218. Gaston-Johansson F., Fall-Dickson J.M., Nanda J., et al. The effectiveness of the comprehensive coping strategy program on clinical outcomes in breast cancer autologous bone marrow transplantation. Cancer Nurs 23 (2000) 277-285
219. Berger A.M., Kuhn B.R., Farr L.A., et al. Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue. Psychooncology 18 (2009) 634-646
220. Savard J., Simard S., Giguere I., et al. Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: Psychological and immunological effects. Palliat Support Care 4 (2006) 219-237
221. Levesque M., Savard J., Simard S., Gauthier J.G., and Ivers H. Efficacy of cognitive therapy for depression among women with metastatic cancer: A single-case experimental study. J Behav Ther Exp Psychiatry 35 (2004) 287-305
222. Montgomery G.H., Kangas M., David D., et al. Fatigue during breast cancer radiotherapy: An initial randomized study of cognitive-behavioral therapy plus hypnosis. Health Psychol 28 (2009) 317-322
223. Schnur J.B., and Montgomery G.H. Hypnosis and cognitive-behavioral therapy during breast cancer radiotherapy: A case report. Am J Clin Hypn 50 (2008) 209-215
224. Courneya K.S., Friedenreich C.M., Sela R.A., Quinney H.A., Rhodes R.E., and Handman M. The group psychotherapy and home-based physical exercise (group-hope) trial in cancer survivors: Physical fitness and quality of life outcomes. Psychooncology 12 (2003) 357-374
225. Goodwin P.J., Leszcz M., Ennis M., et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 345 (2001) 1719-1726
226. Aghabati N., Mohammadi E., and Pour Esmaiel Z. The effect of therapeutic touch on pain and fatigue of cancer patients undergoing chemotherapy. Evid Based Complement Alternat Med (Feb 2, 2008) Epub
227. Danhauer S.C., Tooze J.A., Holder P., Miller C., and Jesse M.T. Healing touch as a supportive intervention for adult acute leukemia patients: A pilot investigation of effects on distress and symptoms. J Soc Integr Oncol 6 (2008) 89-97
228. Montgomery G.H., Bovbjerg D.H., Schnur J.B., et al. A randomized clinical trial of a brief hypnosis intervention to control side effects in breast surgery patients. J Natl Cancer Inst 99 (2007) 1304-1312
229. van Weert E., Hoekstra-Weebers J., Otter R., Postema K., Sanderman R., and van der Schans C. Cancer-related fatigue: Predictors and effects of rehabilitation. Oncologist 11 (2006) 184-196
230. Riesenberg H, Lubbe AS. In-patient rehabilitation of lung cancer patients-a prospective study. Support Care Cancer, in press.
231. Buss T, de Walden-Galuszko K, Modlinska A, Osowicka M, Lichodziejewska-Niemierko M, Janiszewska J. Kinesitherapy alleviates fatigue in terminal hospice cancer patients-an experimental, controlled study. Support Care Cancer, in press.
232. Heim M.E., v d Malsburg M.L., and Niklas A. Randomized controlled trial of a structured training program in breast cancer patients with tumor-related chronic fatigue. Onkologie 30 (2007) 429-434
233. Korstjens I., May A.M., van Weert E., et al. Quality of life after self-management cancer rehabilitation: A randomized controlled trial comparing physical and cognitive-behavioral training versus physical training. Psychosom Med 70 (2008) 422-429
234. van Weert E., Hoekstra-Weebers J.E., May A.M., Korstjens I., Ros W.J., and van der Schans C.P. The development of an evidence-based physical self-management rehabilitation programme for cancer survivors. Patient Educ Couns 71 (2008) 169-190
235. Post-White J., Kinney M.E., Savik K., Gau J.B., Wilcox C., and Lerner I. Therapeutic massage and healing touch improve symptoms in cancer. Integrative Cancer Therapies 2 (2003) 332-344
236. Currin J., and Meister E.A. A hospital-based intervention using massage to reduce distress among oncology patients. Cancer Nurs 31 (2008) 214-221
237. Cassileth B.R., and Vickers A.J. Massage therapy for symptom control: Outcome study at a major cancer center. J Pain Symptom Manage 28 (2004) 244-249
238. Ahles T.A., Tope D.M., Pinkson B., et al. Massage therapy for patients undergoing autologous bone marrow transplantation. J Pain Symptom Manage 18 (1999) 157-163
239. Pruthi S., Degnim A.C., Bauer B.A., DePompolo R.W., and Nayar V. Value of massage therapy for patients in a breast clinic. Clin J Oncol Nurs 13 (2009) 422-425
240. Kieviet-Stijnen A., Visser A., Garssen B., and Hudig W. Mindfulness-based stress reduction training for oncology patients: Patients' appraisal and changes in well-being. Patient Educ Couns 72 (2008) 436-442
241. Carlson L.E., and Garland S.N. Impact of Mindfulness-Based Stress Reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med 12 (2005) 278-285
242. Speca M., Carlson L.E., Goodey E., and Angen M. A randomized, wait-list controlled clinical trial: The effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 62 (2000) 613-622
243. Carlson L.E., Speca M., Patel K.D., and Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med 65 (2003) 571-581
244. Lengacher C.A., Johnson-Mallard V., Post-White J., et al. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology 18 (2009) 1261-1272
245. Clark M., Isaacks-Downton G., Wells N., et al. Use of preferred music to reduce emotional distress and symptom activity during radiation therapy. J Music Ther 43 (2006) 247-265
246. Bozcuk H., Artac M., Kara A., et al. Does music exposure during chemotherapy improve quality of life in early breast cancer patients?. A pilot study. Med Sci Monitor 12 (2006) CR200-CR205
247. Burns D.S., Azzouz F., Sledge R., et al. Music imagery for adults with acute leukemia in protective environments: A feasibility study. Support Care Cancer 16 (2008) 507-513
248. Nakayama H., Kikuta F., and Takeda H. A pilot study on effectiveness of music therapy in hospice in Japan. J Music Ther 46 (2009) 160-172
249. Roscoe J.A., Matteson S.E., Mustian K.M., Padmanaban D., and Morrow G.R. Treatment of radiotherapy-induced fatigue through a nonpharmacological approach. Integr Cancer Ther 4 (2005) 8-13
250. Cohen M., and Fried G. Comparing Relaxation training and cognitive-behavioral group therapy for women with breast cancer. Res Social Work Practice 17 (2007) 313-323
251. Decker T.W., Cline-Elsen J., and Gallagher M. Relaxation therapy as an adjunct in radiation oncology. J Clin Psychol 48 (1992) 388-393
252. Haase O., Schwenk W., Hermann C., and Muller J.M. Guided imagery and relaxation in conventional colorectal resections: A randomized, controlled, partially blinded trial. Dis Colon Rectum 48 (2005) 1955-1963
253. Luebbert K., Dahme B., and Hasenbring M. The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: A meta-analytical review. Psychooncology 10 (2001) 490-502
254. Brown P., Clark M.M., Atherton P., et al. Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?. Am J Clin Oncol 29 (2006) 52-58
255. Ream E., Richardson A., and Alexander-Dann C. Supportive intervention for fatigue in patients undergoing chemotherapy: A randomized controlled trial. J Pain Symptom Manage 31 (2006) 148-161
256. Dolbeault S., Cayrou S., Bredart A., et al. The effectiveness of a psycho-educational group after early-stage breast cancer treatment: Results of a randomized French study. Psychooncology 18 (2009) 647-656
257. Godino C., Jodar L., Duran A., Martinez I., and Schiaffino A. Nursing education as an intervention to decrease fatigue perception in oncology patients. Eur J Oncol Nurs 10 (2006) 150-155
258. Vilela L.D., Nicolau B., Mahmud S., et al. Comparison of psychosocial outcomes in head and neck cancer patients receiving a coping strategies intervention and control subjects receiving no intervention. J Otolaryngol 35 (2006) 88-96
259. Boesen E.H., Ross L., Frederiksen K., et al. Psychoeducational intervention for patients with cutaneous malignant melanoma: A replication study. J Clin Oncol 23 (2005) 1270-1277
260. Lindemalm C., Strang P., Lekander M., and Support group for cancer patients. Does it improve their physical and psychological wellbeing?. A pilot study. Support Care Cancer 13 (2005) 652-657
261. Williams S.A., and Schreier A.M. The role of education in managing fatigue, anxiety, and sleep disorders in women undergoing chemotherapy for breast cancer. Appl Nurs Res 18 (2005) 138-147
262. Yates P., Aranda S., Hargraves M., et al. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 23 (2005) 6027-6036
263. Allison P.J., Edgar L., Nicolau B., Archer J., Black M., and Hier M. Results of a feasibility study for a psycho-educational intervention in head and neck cancer. Psychooncology 13 (2004) 482-485
264. Given B., Given C.W., McCorkle R., et al. Pain and fatigue management: Results of a nursing randomized clinical trial. Oncol Nurs Forum 29 (2002) 949-956
265. Fawzy F.I. A short-term psychoeducational intervention for patients newly diagnosed with cancer. Support Care Cancer 3 (1995) 235-238
266. Fawzy F.I., Cousins N., Fawzy N.W., Kemeny M.E., Elashoff R., and Morton D. A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 47 (1990) 720-725
267. Kim Y., Roscoe J.A., and Morrow G.R. The effects of information and negative effect on severity of side effects from radiation therapy for prostate cancer. Support Care Cancer 10 (2002) 416-421
268. Yesilbalkan O.U., Karadakovan A., and Goker E. The effectiveness of nursing education as an intervention to decrease fatigue in Turkish patients receiving chemotherapy. Oncol Nurs Forum 36 (2009) E215-E222
269. Oh B., Butow P., Mullan B., et al. Impact of Medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: A randomized controlled trial. Ann Oncol 21 (2010) 608-614
270. Tsang K.L., Carlson L.E., and Olson K. Pilot crossover trial of Reiki versus rest for treating cancer-related fatigue. Integrative Cancer Ther 6 (2007) 25-35
271. Kim S.D., and Kim H.S. Effects of a relaxation breathing exercise on anxiety, depression, and leukocyte in hemopoietic stem cell transplantation patients. Cancer Nurs 28 (2005) 79-83
272. Schneider S.M., Ellis M., Coombs W.T., Shonkwiler E.L., and Folsom L.C. Virtual reality intervention for older women with breast cancer. Cyberpsychol Behav 6 (2003) 301-307
273. Schneider S.M., and Hood L.E. Virtual reality: A distraction intervention for chemotherapy. Oncol Nurs Forum 34 (2007) 39-46
274. Schneider S.M., Prince-Paul M., Allen M.J., Silverman P., and Talaba D. Virtual reality as a distraction intervention for women receiving chemotherapy. Oncol Nurs Forum 31 (2004) 81-88
275. Oyama H., Kaneda M., Katsumata N., Akechi T., and Ohsuga M. Using the bedside wellness system during chemotherapy decreases fatigue and emesis in cancer patients. J Med Syst 24 (2000) 173-182
276. Oyama H., Ohsuga M., Tatsuno Y., and Katsumata H. Evaluation of the psycho-oncological effectiveness of the bedside wellness system. Cyberpsychol Behav 2 (1999) 81-84
277. Danhauer S.C., Tooze J.A., Farmer D.F., et al. Restorative yoga for women with ovarian or breast cancer: Findings from a pilot study. J Soc Integr Oncol 6 (2008) 47-58
278. Carson J.W., Carson K.M., Porter L.S., Keefe F.J., Shaw H., and Miller J.M. Yoga for women with metastatic breast cancer: Results from a pilot study. J Pain Symptom Manage 33 (2007) 331-341
279. Culos-Reed S.N., Carlson L.E., Daroux L.M., and Hately-Aldous S. A pilot study of yoga for breast cancer survivors: Physical and psychological benefits. Psychooncology 15 (2006) 891-897
280. Cohen L., Warneke C., Fouladi R.T., Rodriguez M.A., and Chaoul-Reich A. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 100 (2004) 2253-2260
281. Moadel A.B., Shah C., Wylie-Rosett J., et al. Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: Effects on quality of life. J Clin Oncol 25 (2007) 4387-4395
282. Danhauer S.C., Mihalko S.L., Russell G.B., et al. Restorative yoga for women with breast cancer: Findings from a randomized pilot study. Psychooncology 18 (2009) 360-368
283. Carson J.W., Carson K.M., Porter L.S., Keefe F.J., and Seewaldt V.L. Yoga of Awareness program for menopausal symptoms in breast cancer survivors: Results from a randomized trial. Support Care Cancer 17 (2009) 1301-1309
284. Strauss-Blasche G., Gnad E., Ekmekcioglu C., Hladschik B., and Marktl W. Combined inpatient rehabilitation and spa therapy for breast cancer patients: Effects on quality of life and CA 15-3. Cancer Nursing 28 (2005) 390-398
285. Kohara H., Miyauchi T., Suehiro Y., Ueoka H., Takeyama H., and Morita T. Combined modality treatment of aromatherapy, footsoak, and reflexology relieves fatigue in patients with cancer. J Palliative Med 7 (2004) 791-796
286. Dy S.M., Lorenz K.A., Naeim A., Sanati H., Walling A., and Asch S.M. Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea. J Clin Oncol 26 (2008) 3886-3895
287. Escalante C.P., and Manzullo E.F. Cancer-related fatigue: The approach and treatment. J Gen Intern Med 24 Suppl 2 (2009) S412-S416
288. Mustian K.M., Sprod L.K., Palesh O.G., et al. Exercise for the management of side effects and quality of life among cancer survivors. Curr Sports Med Rep 8 (2009) 325-330
289. Conn V.S., Hafdahl A.R., Porock D.C., McDaniel R., and Nielsen P.J. A meta-analysis of exercise interventions among people treated for cancer. Support Care Cancer 14 (2006) 699-712
290. Knols R., Aaronson N.K., Uebelhart D., Fransen J., and Aufdemkampe G. Physical exercise in cancer patients during and after medical treatment: A systematic review of randomized and controlled clinical trials. J Clin Oncol 23 (2005) 3830-3842
291. McNeely M.L., Campbell K.L., Rowe B.H., Klassen T.P., Mackey J.R., and Courneya K.S. Effects of exercise on breast cancer patients and survivors: A systematic review and meta-analysis. CMAJ 175 (2006) 34-41
292. Galvao D.A., and Newton R.U. Review of exercise intervention studies in cancer patients. J Clin Oncol 23 (2005) 899-909
293. Kuchinski A.M., Reading M., and Lash A.A. Treatment-related fatigue and exercise in patients with cancer: A systematic review. Medsurg Nurs 18 (2009) 174-180
294. Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer survivors: A systematic review and meta-analysis. J Cancer Surviv, in press.
295. Thorsen L., Courneya K.S., Stevinson C., and Fosså S.D. A systematic review of physical activity in prostate cancer survivors: Outcomes, prevalence, and determinants. Support Care Cancer 16 (2008) 987-997
296. Labourey J.L. Physical activity in the management of cancer-related fatigue induced by oncological treatments. Ann Readapt Med Phys 50 (2007) 450-454 445-459
297. Seo Y, Oh H, Seo W. Causal relationships among factors associated with cancer-related fatigue. Eur J Oncol Nurs, in press.
298. Klika R.J., Callahan K.E., and Drum S.N. Individualized 12-week exercise training programs enhance aerobic capacity of cancer survivors. Phys Sportsmed 37 (2009) 68-77
299. Spence R.R., Heesch K.C., and Brown W.J. Exercise and cancer rehabilitation: A systematic review. Cancer Treat Rev 36 (2010) 185-194
300. McAuley E., White S.M., Rogers L.Q., Motl R.W., and Courneya K.S. Physical activity and fatigue in breast cancer and multiple sclerosis: Psychosocial mechanisms. Psychosom Med 72 (2010) 88-96
301. Speed-Andrews A.E., and Courneya K.S. Effects of exercise on quality of life and prognosis in cancer survivors. Curr Sports Med Rep 8 (2009) 176-181
302. Humpel N., and Iverson D.C. Review and critique of the quality of exercise recommendations for cancer patients and survivors. Support Care Cancer 13 (2005) 493-502
303. Donnelly CM, Lowe-Strong A, Rankin JP, Campbell A, Allen JM, Gracey JH. Physiotherapy management of cancer-related fatigue: A survey of UK current practice. Support Care Cancer, in press.
304. White S.M., McAuley E., Estabrooks P.A., and Courneya K.S. Translating physical activity interventions for breast cancer survivors into practice: An evaluation of randomized controlled trials. Ann Behav Med 37 (2009) 10-19
305. Jacobsen P.B., Donovan K.A., Vadaparampil S.T., and Small B.J. "Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue": Correction. Health Psychol 27 (2008) 42
306. Barsevick A.M., Dudley W., Beck S., Sweeney C., Whitmer K., and Nail L. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer 100 (2004) 1302-1310
307. Barsevick A.M., Whitmer K., Sweeney C., and Nail L.M. A pilot study examining energy conservation for cancer treatment-related fatigue. Cancer Nurs 25 (2002) 333-341
308. Korstjens I., Mesters I., van der Peet E., Gijsen B., and van den Borne B. Quality of life of cancer survivors after physical and psychosocial rehabilitation. Eur J Cancer Prev 15 (2006) 541-547
309. Carpenter J.S., Storniolo A.M., Johns S., et al. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist 12 (2007) 124-135
310. Lasheen W., Walsh D., Mahmoud F., Davis M.P., Rivera N., and Khoshknabi D.S. Methylphenidate side effects in advanced cancer: A retrospective analysis. Am J Hosp Palliat Care 27 (2010) 16-23
311. Kohli S., Fisher S.G., Tra Y., et al. The effect of modafinil on cognitive function in breast cancer survivors. Cancer 115 (2009) 2605-2616
312. Wilson J., Yao G.L., Raftery J., et al. A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technol Assess 11 (2007) 1-220
313. Jones M., Schenkel B., Just J., and Fallowfield L. Epoetin alfa improves quality of life in patients with cancer: Results of metaanalysis. Cancer 101 (2004) 1720-1732
314. Bottomley A., Thomas R., van Steen K., Flechtner H., and Djulbegovic B. Human recombinant erythropoietin and quality of life: A wonder drug or something to wonder about?. Lancet Oncol 3 (2002) 145-153
315. Cella D., Dobrez D., and Glaspy J. Control of cancer-related anemia with erythropoietic agents: A review of evidence for improved quality of life and clinical outcomes. Ann Oncol 14 (2003) 511-519
316. Littlewood T.J., Cella D., and Nortier J.W. Erythropoietin improves quality of life. Lancet Oncol 3 (2002) 459-460
317. Bohlius J., Schmidlin K., Brillant C., et al. Erythropoietin or darbepoetin for patients with cancer-meta-analysis based on individual patient data. Cochrane Database Syst Rev 3 (2009) CD007303
318. Glaspy J., Crawford J., Vansteenkiste J., et al. Erythropoiesis-stimulating agents in oncology: A study-level meta-analysis of survival and other safety outcomes. Br J Cancer 102 (2010) 301-315
319. Stasi R., Amadori S., Littlewood T.J., Terzoli E., Newland A.C., and Provan D. Management of cancer-related anemia with erythropoietic agents: Doubts, certainties, and concerns. Oncologist 10 (2005) 539-554
320. Steensma D.P., and Loprinzi C.L. Erythropoietin use in cancer patients: A matter of life and death?. J Clin Oncol 23 (2005) 5865-5868
321. Littlewood T., and Collins G. Epoetin alfa: Basic biology and clinical utility in cancer patients. Expert Rev Anticancer Ther 5 (2005) 947-956
322. Hershman D.L., Buono D.L., Malin J., McBride R., Tsai W.Y., and Neugut A.I. Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer. J Natl Cancer Inst 101 (2009) 1633-1641
323. Glaspy J.A. The development of erythropoietic agents in oncology. Expert Opin Emerg Drugs 10 (2005) 553-567
324. Cancer- and chemotherapy-induced anemia (version 2.2010). National Comprehensive Cancer Network (2010). http://www.nccn.org/professionals/physician_gls/PDF/anemia.pdf Accessed February 14, 2010
325. Rizzo J.D., Somerfield M.R., Hagerty K.L., et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. Blood 111 (2008) 25-41
326. Jain S., and Mills P.J. Biofield therapies: Helpful or full of hype? A best evidence synthesis. Int J Behav Med 17 (2010) 1-16
327. Kwekkeboom K.L., Cherwin C.H., Lee J.W., and Wanta B. Mind-body treatments for the pain-fatigue-sleep disturbance symptom cluster in persons with cancer. J Pain Symptom Manage 39 (2010) 126-138
328. Linden W., and Satin J.R. Avoidable pitfalls in behavioral medicine outcome research. Ann Behav Med 33 (2007) 143-147